About the Conference

Citations International aims to bring together front-line experts from multidisciplinary research and application areas to join this conference, to discuss the ongoing Research and Development efforts in the field of Pharmacology and Pharmaceutical Sciences. 

Importance:

With the development of specific and potent synthetic drugs, the emphasis of the pharmacist’s responsibility has moved substantially towards the utilization of scientific knowledge in the proper use of modern medicines and the protection of the public against dangers that are inherent in their use.

Pharmacists are employed in regulatory control and drug management, community pharmacy, hospital pharmacy, the pharmaceutical industry, academic activities, training of other health workers, and research. In all these fields, their aim is to ensure optimum drug therapy, both by contributing to the preparation, supply and control of medicines and associated products, and by providing information and advice to those who prescribe or use pharmaceutical products.

Conference Highlights:

Pharmaceutics/Pharmaceutical Technology

Pharmacology

Clinical and Hospital Pharmacy

Pharmaceutical/ Phytochemistry

Social Pharmacy

Biopharmaceutics

Pharmacy Practice

Pharmaceutical Chemistry

Drug Discovery and Development

Protein-Protein Interactions as Drug Targets

Pharmaceutical Drug Development

Drug Discovery & Research

Clinical Trials & Research Advancements

Novel Drug Delivery System

Bio Availability and Bioequivalence

Drug Formulation & Evaluation

Drug Delivery Systems & Metabolism

Regulatory Affairs and Intellectual Property Rights

Documentation

Pharmaceutical Analysis

Biosimilars & Research Developments

Drug Safety

Pharma covigilance

Data Integrity in Pharma

Advances in Pharmacological Research

Adverse Drug Reactions

Bio and Chemo informatics

Entrepreneurs Investment Meet

Adrenergic Drugs

Anesthesia Pharmacology

Antibiotics

Application of membrane protein structure determination and its applications in drug design

Chemotherapy and other antineoplastic drugs

Cholinergic Drugs

Clinical Pharmacology

Design and optimization of dosage regimens

Drug Development

Drug metabolism & interactions

Narcotic

Nursing Pharmacology

Personalized Medicine

Pharmaceutical crops

Pharmaceuticals testing

Pharmacogenetics

Pharmacogenomics

Pharmacokinetics and Pharmacodynamics

Serotonin Pharmacology

Characterization of Drugs and Biotherapeutics

Applications of ADME in Early Drug Discovery

Rapid Methods to Assess Quality & Stability of Biotherapeutics

Target Audiences:

Pharmacy research Students, Scientists

Pharmacy research Faculty

Medical Colleges

Pharmacy Associations and Societies

Pharmacologists

Pharmacists

Pharmaceutical chemists

Pathologists

Business Entrepreneurs

Medical Devices Manufacturing Companies

Pharmaceutical Companies

Diagnostics Companies

Benefits of joining the Conference:

Citations International affords a tremendous opportunity to join in this forum to utilize the expertise and novelties that expands the participant’s views in the field of . We also aim to bring together front-line experts from multidisciplinary research and application areas to join this conference, to discuss the ongoing Research and Development efforts in the field of.

Pharmacology and Pharmaceutical Sciences Organizations around the World:

Commonwealth Pharmacists Association

International Pharmaceutical Federation

Royal Pharmaceutical Society of Great Britain

International Pharmaceutical Students' Federation

European Association of Employed Community Pharmacists in Europe

European Pharmaceutical Union

Pharmaceutical Group of the European Union

Australian College of Pharmacy

Pharmaceutical Society of Australia

The Pharmacy Guild of Australia

The Pharmacy Guild of Australia

Canadian Pharmacists Association

Canadian Society of Hospital Pharmacists

Chinese Pharmaceutical Association

Danish Association of Pharmaconomists

Indian Pharmacist Association

Pharmaceutical Society of Ireland

The Pharmaceutical Association of Israel

Kuwait Pharmaceutical Association

Kuwait Pharmaceutical Association

Pharmaceutical Society Of New Zealand

Norwegian Pharmacy Association

Pakistan Pharmacists Association

Philippine Pharmacists Association

National Pharmacy Association

Pharmaceutical Society of Northern Ireland

Royal Pharmaceutical Society

American Association of Colleges of Pharmacy

American Pharmacists Association

American Society for Pharmacy Law

American Society of Consultant Pharmacists

American Society of Consultant Pharmacists Foundation

American Society of Health-System Pharmacists

Professional Compounding Centers of America

American College of Clinical Pharmacy

Association of the British Pharmaceutical Industry

British National Formulary

British National Formulary for Children

British Pharmacopoeia Commission

Cochrane Collaboration

Commission on Human Medicines

Department of Health

Drug Scope

General Pharmaceutical Council

Medicines and Healthcare products Regulatory Agency

National Institute for Health and Clinical Excellence

National Patient Safety Agency

NHS Confederation

Pharmaceutical Services Negotiating Committee

Pharmaceutical Society of Northern Ireland

Pharmacists' Defence Association

Royal Pharmaceutical Society

Scottish Medicines Consortium

UK Clinical Pharmacy Association

Worshipful Society of Apothecaries of London

Market Analysis:

Global pharmaceutical packaging market is expected to reach $104,882 million by 2022 from $68,749 million in 2015, growing at a CAGR of 6.27% from 2016 to 2022. This market is expected to witness notable growth in the coming years, owing to the increased R&D, new innovations in packaging materials, growth in generic market, and rise in trend of contract packaging. Growth in demand for reusable and eco-friendly packaging is also expected to drive the market. The pharmaceutical drug manufacturing companies have started to adopt eco-friendly pharmaceutical packages to overcome environmental concerns. Technological advancements in pharmaceutical packaging solutions offer immense innovative and advanced applications to the pharmaceutical & biopharmaceutical industries to improve their packaging standards. The impact of these drivers is expected to increase significantly due to increase in awareness about various diseases, rise in self-medication, and growth in usage of OTC drugs. The cost of pharmaceutical packaging is expected to reduce with the advancement in technology and eco-friendly packaging. The introduction of nano-enabled packaging is projected to have a positive impact on this market.

            The primary raw materials used in pharmaceutical packaging are resins, plastics, and films. Packaging adhesives are the secondary raw materials used in the pharmaceutical packaging industry. The sustained interruption in the supply of these raw materials also leads to a significant increase in their prices and impedes the production of pharmaceutical packages. It is important for innovators to understand the extensive network of regulations that may affect an innovation. For instance, the basic requirements for flexible packaging materials as per the U.S. FDA are that the product should be manufactured as per Good Manufacturing Process Regulation (cGMP) Guidelines provided under directive 21 CFR part 11.

Pharmaceutical Packaging Industry Segmentation

Pharmaceuticals packaging market is segmented based on product type and geography. Based on product type, it consists of plastic bottles, parenteral containers, blister packaging, specialty bags, closures, labels, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Increase in healthcare investments and medicinal advancements are key factors that fuel the growth of pharmaceutical packaging market. In LAMEA, the market is anticipated to grow at a CAGR of 7.14% between 2016 and 2022.

For instance, the Latin America market is anticipated to witness a CAGR of 6.51% during the forecast period.

Latin America Pharmaceutical Packaging Market Size, 2014-2022 ($Million)

Porter’s Five Forces Analysis:

Several established suppliers hold a significantly notable proportion of the market share, thereby decreasing the bargaining power of the suppliers. Pharmaceutical packaging raw material suppliers need to develop differentiated products owing to rising demand for customized features by customers. In addition, switching cost in this case is low. Corporate buyers of pharmaceutical packaging companies are knowledgeable and aware about the packaging features and their competitors’ offerings. This increases the bargaining power of the buyer. There are limited substitutes available in the pharmaceutical packaging market that offers similar products and solutions. However, consumers still prefer the traditional packages due to their low cost. Therefore, the threat of substitutes is low at present. Stringent government regulations towards the environment, labeling requirements, and fluctuating prices of drugs and raw materials are major factors that limit the new entrants to invest in this market. Owing to the presence of many players in the market, there is high rivalry within competitors to increase their market share. In such a competitive scenario, the organizations try to limit their competitor’s profitability.

Market Dynamics:

Drivers:

The advanced manufacturing processes used to develop pharmaceutical packages play a pivotal role in the growth of the global pharmaceutical packaging market. Advanced manufacturing processes, including green packaging technologies, use environment-friendly materials to develop pharmaceutical packages, which inflict minimal harm to the environment. The designs of these biodegradable and eco-friendly packaging materials are replacing the existing conventional packaging materials. The raw materials used for eco-friendly packaging include paper, cardboard, and corn starch. The use of biodegradable materials supports sustainability of all stages of pharmaceutical product lifecycle; thus, pharmaceutical manufacturers increase the demand for sustainable packaging.

Restraints:

The price volatility of raw materials used in pharmaceutical packaging restrains the growth of the market. The raw material and packaging costs have increased significantly in the last few years, and it is also expected that the prices will increase overall along with changes in ecological measures.

Pharmaceutical Packaging Market Share Analysis

In 2015, Amcor dominated the pharmaceuticals packaging market followed by Gerresheimer. Prominent players profiled in this market include Berry Plastics, Corporation, Becton Dickinson and Company, MeadWestvaco Corporation, West Pharmaceuticals Services Inc Owens-Illinois, RPC Group, Schott Pharmaceuticals Services Inc., and Graphic Packaging Group.

Other key players (not profiled in the report) in the market value chain include Aptar Group Inc, Westrock and Catalent Pharma Solutions Inc., Anchor Packaging, Ball Corporation, 3M, Sealed Air Corporation, Baxter International Inc., Centor and Lilly (Eli) Company, Unilife Corporation, Exporta Global, and Plastube Inc.

Key Benefits for Stakeholders:

The market research provides a quantitative and qualitative analysis of the current pharmaceutical packaging industry trends and estimations through 2014‐2022, which assist in identifying the prevailing market opportunities in different segments.

Pharmaceutical packaging industry report define trends in major countries in each region are mapped according to the estimated market revenue.

Pharmaceutical packaging industry overview across different products used in packaging is analyzed.

Focused study of the factors that drive and restrict the pharmaceutical packaging industry growth are provided.

Key manufactures of pharmaceutical packaging are profiled and their recent developments are listed.

 Source: - https://www.alliedmarketresearch.com

Figure: Statistical Analysis

Glance at the Market:

The international in vitro toxicology testing market is expected to USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016, at a CAGR of 14.1% between 2016 and 2021. Toxicity testing of new compounds is  important in drug development, as identifying the possible toxicity at an early stage in drug discovery can save both time and developmental costs, and also reduce the probability of late-stage failure.

Opposition to animal testing, new & promising technologies, increasing R&D to notice toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving factors of the in vitro toxicology testing market. On the other hand lack of in vitro models to detect autoimmunity and immune stimulation and predictive ability of in vitro testing over in vivo testing are the major factor warning the growth of this market.

Figure: Global In Vitro Toxicity Market Estimates and Forecast, 2011-2021 (USD Billions)

Glance at the Pharmaceutical Market in UAE:

In 2013, the UAE's population stood at 9 million, an increase from 8.1 million in 2008. The United Arab Emirates' pharmaceutical market was estimated to have been worth $2.4 billion in 2013 and is expected to reach $3.7 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 5.3%. The UAE's medical device market was valued at approximately $600.2m in 2008, and $733.3m in 2013. The medical device market is expected to reach $978.9m in 2020 at a CAGR of 4.2% from 2014. The positive trends in UAE's healthcare market can mainly be attributed to the increasing coverage of healthcare assurance and government initiatives to progress healthcare facilities.

Figure: UAE's Pharmaceutical Market Estimates and Forecast, 2011-2020 (USD Billions)

 

Pharmaceuticals & Healthcare in UAE:

Headline Pharmaceuticals & Healthcare Forecasts (United Arab Emirates 2014-2020)

 

2014

2015

2016f

2017f

2018f

2019f

2020f

f = BMI forecast. Source: WHO, National Sources, BMI

Pharmaceutical sales, USDbn

4.450

2.930

3.170

3.410

3.670

3.940

4.220

Pharmaceutical sales, % of GDP

1.11

0.79

0.81

0.83

0.85

0.86

0.87

Pharmaceutical sales, % of health expenditure

30.4

19.2

19.7

20.2

20.6

20.9

21.2

Health spending, USDbn

14.630

15.320

16.080

16.910

17.820

18.820

19.930

 

Figure: Pharmaceutical sales in UAE (USD Billions)

 The UAE is one of the most pleasing markets for pharmaceutical and healthcare providers in the Middle East and African region. It has a fast-growing private healthcare sector, which brings with it demand for original and patented drugs.

Source: http://toxicology-pharmacology.conferenceseries.com/#section2

 


Contact Us


Follow Us